
Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Saurav Chatterjee, Subhankar Maitra, Anasua ChakrabortyVolume:
163
Année:
2012
Langue:
english
Pages:
1
DOI:
10.1016/j.ahj.2011.10.004
Fichier:
PDF, 58 KB
english, 2012